Christian Bruehlmann

Christian is Chief Business Officer and co-founder of Proteomedix AG, a Swiss healthcare company whose mission is to transform prostate cancer diagnosis.
He gained 20 years of experience in public and private companies in the life sciences, information and communications (ICT) and financial industries.
Being responsible for business development, finance and product management, he was instrumental in Proteomedix’ development from inception to the market introduction of the lead product Proclarix, a blood based prostate cancer test panel and risk score, and the successful exit with a NASDAQ-listed company.
Previously, he worked for Swisscom, Switzerland's telecom market leader in several strategic and leadership roles in the area of digitalization.
Christian received his Master in Business Administration from University of Zurich, Switzerland and completed executive professional trainings at the Babson College, USA and at the University of St. Gallen, Switzerland.